Sanofi global operations president to retire

pharmafile | December 20, 2012 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Hanspeter Spek, Sanofi 

Sanofi has announced that Hanspeter Spek, president, Global Operations, will retire from his current role in mid-2013. 

Christopher Viehbacher, chief executive of Sanofi said: “During his many years with Sanofi, Hanspeter has made an exceptional contribution to the success of the Group and has helped bring Sanofi to the forefront of the industry.

“His early recognition of growing opportunities in the emerging markets has contributed to the building of Sanofi’s leading position there. With the Group now having an outlook of long-term sustainable growth, I would like to sincerely thank Hanspeter for his leadership, commitment and energy and wish him the very best for the future”.

Advertisement

Spek joined the Group in 1985 as marketing director with Sanofi Pharma GmbH Germany. Throughout his tenure, he worked his way up through the Group and was appointed to his current position as president, Global Operations in November 2009.

Spek will retain his role as chairman of the Supervisory Board of Sanofi GmbH Germany during a transitional period.

Related Content

Excellence in Healthcare Partnership Awards – A Collaborative Working Project Between Sanofi and The University Hospital Birmingham Severe Asthma Team

Launched in February 2026 by PMGroup Worldwide Ltd and Visions4Health, the Excellence in Healthcare Partnerships …

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria

Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee …

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition

The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) …

The Gateway to Local Adoption Series

Latest content